ICD-10-CM Billable Code

Z67.A4

Duffy a and b positive

Clinical Classification Guidelines

Inclusion Terms

  • Duffy phenotype Fy(a+b+)

Medical Intelligence & Overview

Duffy a and b positive, classified under the ICD-10 code Z67.A4, refers to a specific blood phenotype characterized by the presence of Duffy antigens, specifically Fy(a+b+). The Duffy blood group system is an important aspect of human blood typing and plays a role in susceptibility to certain infections. This phenotype is used in medical contexts such as blood transfusions and research related to infectious diseases, notably malaria. Understanding your Duffy blood group status can be helpful for healthcare providers in managing transfusions and understanding immune responses.

Causes & Symptoms

Clinical Causes: Genetic inheritance: The Duffy blood group phenotype Fy(a+b+) is inherited from your parents based on specific gene variants. Duffy antigen expression: The phenotype results from the presence of specific alleles that encode the Duffy glycoprotein on red blood cells. Population genetics: The distribution of the Fy(a+b+) phenotype varies among different ethnic groups and populations.

Key Symptoms: Typically, there are no symptoms directly associated with Duffy a and b positivity because it is a blood group phenotype. Its significance may become evident in particular contexts, such as blood compatibility testing or susceptibility to certain infections.

Diagnostic & Treatment

Diagnosis Path: The Duffy a and b positive phenotype is determined through blood testing techniques such as serologic testing or molecular methods. These tests identify the presence of Duffy antigens on red blood cells and confirm the specific phenotype. Blood banks and laboratories can perform these tests to classify your blood group and ensure compatibility in transfusions.

Treatment Protocols: Since the Duffy a and b positive status is a genetic trait rather than a medical condition, there is no treatment required. However, this information can be valuable for planning blood transfusions and understanding individual susceptibility to certain diseases. In cases where individuals are involved in medical procedures or research, knowing their Duffy status assists healthcare professionals in making informed decisions.

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is Z67.A4 a billable ICD-10 code?
Yes, Z67.A4 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report Z67.A4?
Clinical documentation must specify the nature of Duffy a and b positive and any associated comorbidities for accurate reporting.

Cite this Clinical Reference

Clinical Meta Tags

positive duffy